Economy/Home · Economy

PeptroN Rises to 98,000 Won... Luprone's Mexico Approval Raises Expectations for Latin America Expansion

PeptroN is showing an upward trend early in the trading session on the 13th. The company's stock price is reflecting growing attention to the potential for overseas market expansion following its acquisition of Mexican product approval for its independently developed long-acting drug 'Luprone.' On

Wooil Shim
Staff Reporter
4 min read
PeptroN Rises to 98,000 Won... Luprone's Mexico Approval Raises Expectations for Latin America Expansion
CBC News

PeptroN is showing an upward trend early in the trading session on the 13th. The company's stock price is reflecting growing attention to the potential for overseas market expansion following its acquisition of Mexican product approval for its independently developed long-acting drug 'Luprone.'

On the morning of the 13th, PeptroN (087010) was trading at 98,000 won, up 1,000 won from the previous trading day, a gain of about 1.03%.

Luprone Approved in Mexico Under the Name 'Lupunia'

PeptroN announced on the 9th that it had obtained product approval for Luprone (PT105) from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS), the country's pharmaceutical regulatory authority. The product name approved in Mexico is 'Lupunia.'

PeptroN plans to use Mexico as a strategic foothold for entering the Latin American market. The company is proceeding with follow-up procedures for local supply and sales while also working to secure business partners.

Latin American Leuprorelin Cancer Drug Market Shows Growth

The market for leuprorelin-based cancer drugs in Latin America reportedly expanded from 14.68 million dollars in 2018 to 35.79 million dollars in 2023.

However, obtaining product approval does not immediately translate into revenue generation. Actual sales require follow-up procedures, including establishing local distribution networks and supply contracts.

With approvals now secured overseas following domestic approval, attention is focused on whether this will lead to actual supply and sales. As PeptroN rises to 98,000 won, the local sales schedule in Mexico and whether the company will pursue product approvals in additional countries are expected to be key points of interest in the market going forward.

[Some AI assistance was used in the writing of this article. This article does not recommend buying or selling specific stocks, and investment decisions and responsibilities rest with the investor.]

Wooil Shim
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.